title: Cutaneous anthrax: a concise review.
abstract: With the growing threat of bioterrorism, it has become important for clinicians to recognize the clinical manifestations of diseases spread in this manner. The aim of this article is to provide readers with a complete and detailed understanding of anthrax, with a specific concentration on the cutaneous manifestations and a concentrated review of the treatment and current information known about Bacillus anthracis.
authors.affiliation: Department of Dermatology, St. Luke's-Roosevelt Medical Center, New York, New York 10025, USA.
authors.forename: William D
authors.initials: WD
authors.lastname: Tutrone
authors.forename: Noah S
authors.initials: NS
authors.lastname: Scheinfeld
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Weinberg
mesh_terms: D000284:Administration, Oral; D000881:Anthrax / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000008:administration & dosage; D002939:Ciprofloxacin / Q000008:administration & dosage; D004318:Doxycycline / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005148:Facial Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D006229:Hand Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D006801:Humans; D007262:Infusions, Intravenous; D017192:Skin Diseases, Bacterial / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D004318:Doxycycline